Biocept reported $47.58M in Current Assets for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Assets Change
Becton, Dickinson and BDX:US $ 9547M 605M
Biocept BIOC:US $ 47.58M 1.89M
Celldex Therapeutics CLDX:US $ 367.98M 22.72M
Cerulean Pharma CERU:US $ 47.82M 7.48M
Cytori Therapeutics CYTX:US $ 18.89M 3.22M
General Electric GE:US 60.66B 2.64B
Illumina ILMN:US $ 2891M 136M
Quest Diagnostics DGX:US $ 2426M 49M
Thermo Fisher Scientific TMO:US $ 18100M 676M